{"id":"https://openalex.org/W2124278256","doi":"https://doi.org/10.1021/mp100175a","title":"High-Permeability Criterion for BCS Classification: Segmental/pH Dependent Permeability Considerations","display_name":"High-Permeability Criterion for BCS Classification: Segmental/pH Dependent Permeability Considerations","alternate_titles":[],"publication_year":2010,"publication_date":"2010-09-03","ids":{"openalex":"https://openalex.org/W2124278256","doi":"https://doi.org/10.1021/mp100175a","mag":"2124278256","pmid":"https://pubmed.ncbi.nlm.nih.gov/20701326"},"language":"en","primary_location":{"id":"doi:10.1021/mp100175a","doi":"https://doi.org/10.1021/mp100175a","is_oa":false,"landing_page_url":"https://doi.org/10.1021/mp100175a","pdf_url":null,"source":{"id":"https://openalex.org/S204562082","display_name":"Molecular Pharmaceutics","issn_l":"1543-8384","issn":["1543-8384","1543-8392"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmaceutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2124278256"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029193787","display_name":"Arik Dahan","orcid":"https://orcid.org/0000-0002-3498-3514","observed_orcids":["https://orcid.org/0000-0002-3498-3514"]},"institutions":[{"id":"https://openalex.org/I102826571","display_name":"Setsunan University","ror":"https://ror.org/0418a3v02","country_code":"JP","type":"education","lineage":["https://openalex.org/I102826571"]},{"id":"https://openalex.org/I124227911","display_name":"Ben-Gurion University of the Negev","ror":"https://ror.org/05tkyf982","country_code":"IL","type":"education","lineage":["https://openalex.org/I124227911"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]},{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]},{"id":"https://openalex.org/I4210114445","display_name":"Michigan Medicine","ror":"https://ror.org/01zcpa714","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210114445"]},{"id":"https://openalex.org/I4210127861","display_name":"Therapeutics Systems Research Laboratories (United States)","ror":"https://ror.org/03hbd7c15","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127861"]}],"countries":["IL","JP","US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Arik Dahan","raw_affiliation_strings":["Department of Clinical Pharmacology, School of Pharmacy, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel, Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109, TSRL, Inc., 540 Avis Drive, Suite A, Ann Arbor, Michigan 48108, Faculty of Pharmaceutical Sciences, Setsunan University, Osaka, Japan, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, Maryland 20857, and Department of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, School of Pharmacy, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel, Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109, TSRL, Inc., 540 Avis Drive, Suite A, Ann Arbor, Michigan 48108, Faculty of Pharmaceutical Sciences, Setsunan University, Osaka, Japan, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, Maryland 20857, and Department of","institution_ids":["https://openalex.org/I102826571","https://openalex.org/I124227911","https://openalex.org/I1333606569","https://openalex.org/I27837315","https://openalex.org/I4210114445","https://openalex.org/I4210127861"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054427131","display_name":"Jonathan M. Miller","orcid":"https://orcid.org/0000-0001-5417-5170","observed_orcids":["https://orcid.org/0000-0001-5417-5170"]},"institutions":[{"id":"https://openalex.org/I102826571","display_name":"Setsunan University","ror":"https://ror.org/0418a3v02","country_code":"JP","type":"education","lineage":["https://openalex.org/I102826571"]},{"id":"https://openalex.org/I124227911","display_name":"Ben-Gurion University of the Negev","ror":"https://ror.org/05tkyf982","country_code":"IL","type":"education","lineage":["https://openalex.org/I124227911"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]},{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]},{"id":"https://openalex.org/I4210114445","display_name":"Michigan Medicine","ror":"https://ror.org/01zcpa714","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210114445"]},{"id":"https://openalex.org/I4210127861","display_name":"Therapeutics Systems Research Laboratories (United States)","ror":"https://ror.org/03hbd7c15","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127861"]}],"countries":["IL","JP","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jonathan M. Miller","raw_affiliation_strings":["Department of Clinical Pharmacology, School of Pharmacy, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel, Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109, TSRL, Inc., 540 Avis Drive, Suite A, Ann Arbor, Michigan 48108, Faculty of Pharmaceutical Sciences, Setsunan University, Osaka, Japan, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, Maryland 20857, and Department of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, School of Pharmacy, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel, Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109, TSRL, Inc., 540 Avis Drive, Suite A, Ann Arbor, Michigan 48108, Faculty of Pharmaceutical Sciences, Setsunan University, Osaka, Japan, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, Maryland 20857, and Department of","institution_ids":["https://openalex.org/I102826571","https://openalex.org/I124227911","https://openalex.org/I1333606569","https://openalex.org/I27837315","https://openalex.org/I4210114445","https://openalex.org/I4210127861"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112712077","display_name":"John M. Hilfinger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I102826571","display_name":"Setsunan University","ror":"https://ror.org/0418a3v02","country_code":"JP","type":"education","lineage":["https://openalex.org/I102826571"]},{"id":"https://openalex.org/I124227911","display_name":"Ben-Gurion University of the Negev","ror":"https://ror.org/05tkyf982","country_code":"IL","type":"education","lineage":["https://openalex.org/I124227911"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]},{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]},{"id":"https://openalex.org/I4210114445","display_name":"Michigan Medicine","ror":"https://ror.org/01zcpa714","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210114445"]},{"id":"https://openalex.org/I4210127861","display_name":"Therapeutics Systems Research Laboratories (United States)","ror":"https://ror.org/03hbd7c15","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127861"]}],"countries":["IL","JP","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"John M. Hilfinger","raw_affiliation_strings":["Department of Clinical Pharmacology, School of Pharmacy, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel, Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109, TSRL, Inc., 540 Avis Drive, Suite A, Ann Arbor, Michigan 48108, Faculty of Pharmaceutical Sciences, Setsunan University, Osaka, Japan, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, Maryland 20857, and Department of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, School of Pharmacy, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel, Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109, TSRL, Inc., 540 Avis Drive, Suite A, Ann Arbor, Michigan 48108, Faculty of Pharmaceutical Sciences, Setsunan University, Osaka, Japan, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, Maryland 20857, and Department of","institution_ids":["https://openalex.org/I102826571","https://openalex.org/I124227911","https://openalex.org/I1333606569","https://openalex.org/I27837315","https://openalex.org/I4210114445","https://openalex.org/I4210127861"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105935513","display_name":"Shinji Yamashita","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I102826571","display_name":"Setsunan University","ror":"https://ror.org/0418a3v02","country_code":"JP","type":"education","lineage":["https://openalex.org/I102826571"]},{"id":"https://openalex.org/I124227911","display_name":"Ben-Gurion University of the Negev","ror":"https://ror.org/05tkyf982","country_code":"IL","type":"education","lineage":["https://openalex.org/I124227911"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]},{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]},{"id":"https://openalex.org/I4210114445","display_name":"Michigan Medicine","ror":"https://ror.org/01zcpa714","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210114445"]},{"id":"https://openalex.org/I4210127861","display_name":"Therapeutics Systems Research Laboratories (United States)","ror":"https://ror.org/03hbd7c15","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127861"]}],"countries":["IL","JP","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Shinji Yamashita","raw_affiliation_strings":["Department of Clinical Pharmacology, School of Pharmacy, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel, Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109, TSRL, Inc., 540 Avis Drive, Suite A, Ann Arbor, Michigan 48108, Faculty of Pharmaceutical Sciences, Setsunan University, Osaka, Japan, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, Maryland 20857, and Department of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, School of Pharmacy, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel, Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109, TSRL, Inc., 540 Avis Drive, Suite A, Ann Arbor, Michigan 48108, Faculty of Pharmaceutical Sciences, Setsunan University, Osaka, Japan, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, Maryland 20857, and Department of","institution_ids":["https://openalex.org/I102826571","https://openalex.org/I124227911","https://openalex.org/I1333606569","https://openalex.org/I27837315","https://openalex.org/I4210114445","https://openalex.org/I4210127861"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103480383","display_name":"Lawrence X. Yu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I102826571","display_name":"Setsunan University","ror":"https://ror.org/0418a3v02","country_code":"JP","type":"education","lineage":["https://openalex.org/I102826571"]},{"id":"https://openalex.org/I124227911","display_name":"Ben-Gurion University of the Negev","ror":"https://ror.org/05tkyf982","country_code":"IL","type":"education","lineage":["https://openalex.org/I124227911"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]},{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]},{"id":"https://openalex.org/I4210114445","display_name":"Michigan Medicine","ror":"https://ror.org/01zcpa714","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210114445"]},{"id":"https://openalex.org/I4210127861","display_name":"Therapeutics Systems Research Laboratories (United States)","ror":"https://ror.org/03hbd7c15","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127861"]}],"countries":["IL","JP","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lawrence X. Yu","raw_affiliation_strings":["Department of Clinical Pharmacology, School of Pharmacy, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel, Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109, TSRL, Inc., 540 Avis Drive, Suite A, Ann Arbor, Michigan 48108, Faculty of Pharmaceutical Sciences, Setsunan University, Osaka, Japan, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, Maryland 20857, and Department of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, School of Pharmacy, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel, Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109, TSRL, Inc., 540 Avis Drive, Suite A, Ann Arbor, Michigan 48108, Faculty of Pharmaceutical Sciences, Setsunan University, Osaka, Japan, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, Maryland 20857, and Department of","institution_ids":["https://openalex.org/I102826571","https://openalex.org/I124227911","https://openalex.org/I1333606569","https://openalex.org/I27837315","https://openalex.org/I4210114445","https://openalex.org/I4210127861"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088832801","display_name":"Hans Lennern\u00e4s","orcid":"https://orcid.org/0000-0002-1578-5184","observed_orcids":["https://orcid.org/0000-0002-1578-5184"]},"institutions":[{"id":"https://openalex.org/I102826571","display_name":"Setsunan University","ror":"https://ror.org/0418a3v02","country_code":"JP","type":"education","lineage":["https://openalex.org/I102826571"]},{"id":"https://openalex.org/I124227911","display_name":"Ben-Gurion University of the Negev","ror":"https://ror.org/05tkyf982","country_code":"IL","type":"education","lineage":["https://openalex.org/I124227911"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]},{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]},{"id":"https://openalex.org/I4210114445","display_name":"Michigan Medicine","ror":"https://ror.org/01zcpa714","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210114445"]},{"id":"https://openalex.org/I4210127861","display_name":"Therapeutics Systems Research Laboratories (United States)","ror":"https://ror.org/03hbd7c15","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127861"]}],"countries":["IL","JP","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hans Lennern\u00e4s","raw_affiliation_strings":["Department of Clinical Pharmacology, School of Pharmacy, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel, Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109, TSRL, Inc., 540 Avis Drive, Suite A, Ann Arbor, Michigan 48108, Faculty of Pharmaceutical Sciences, Setsunan University, Osaka, Japan, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, Maryland 20857, and Department of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, School of Pharmacy, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel, Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109, TSRL, Inc., 540 Avis Drive, Suite A, Ann Arbor, Michigan 48108, Faculty of Pharmaceutical Sciences, Setsunan University, Osaka, Japan, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, Maryland 20857, and Department of","institution_ids":["https://openalex.org/I102826571","https://openalex.org/I124227911","https://openalex.org/I1333606569","https://openalex.org/I27837315","https://openalex.org/I4210114445","https://openalex.org/I4210127861"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5085453188","display_name":"Gordon L. Amidon","orcid":"https://orcid.org/0000-0003-0355-911X","observed_orcids":["https://orcid.org/0000-0003-0355-911X"]},"institutions":[{"id":"https://openalex.org/I102826571","display_name":"Setsunan University","ror":"https://ror.org/0418a3v02","country_code":"JP","type":"education","lineage":["https://openalex.org/I102826571"]},{"id":"https://openalex.org/I124227911","display_name":"Ben-Gurion University of the Negev","ror":"https://ror.org/05tkyf982","country_code":"IL","type":"education","lineage":["https://openalex.org/I124227911"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]},{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]},{"id":"https://openalex.org/I4210114445","display_name":"Michigan Medicine","ror":"https://ror.org/01zcpa714","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210114445"]},{"id":"https://openalex.org/I4210127861","display_name":"Therapeutics Systems Research Laboratories (United States)","ror":"https://ror.org/03hbd7c15","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127861"]}],"countries":["IL","JP","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gordon L. Amidon","raw_affiliation_strings":["Department of Clinical Pharmacology, School of Pharmacy, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel, Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109, TSRL, Inc., 540 Avis Drive, Suite A, Ann Arbor, Michigan 48108, Faculty of Pharmaceutical Sciences, Setsunan University, Osaka, Japan, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, Maryland 20857, and Department of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, School of Pharmacy, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel, Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109, TSRL, Inc., 540 Avis Drive, Suite A, Ann Arbor, Michigan 48108, Faculty of Pharmaceutical Sciences, Setsunan University, Osaka, Japan, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, Maryland 20857, and Department of","institution_ids":["https://openalex.org/I102826571","https://openalex.org/I124227911","https://openalex.org/I1333606569","https://openalex.org/I27837315","https://openalex.org/I4210114445","https://openalex.org/I4210127861"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5029193787"],"corresponding_institution_ids":["https://openalex.org/I102826571","https://openalex.org/I124227911","https://openalex.org/I1333606569","https://openalex.org/I27837315","https://openalex.org/I4210114445","https://openalex.org/I4210127861"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":6.8867,"has_fulltext":false,"cited_by_count":107,"citation_normalized_percentile":{"value":0.98321611,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":100},"biblio":{"volume":"7","issue":"5","first_page":"1827","last_page":"1834"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.986299991607666,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.986299991607666,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.006899999920278788,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bcs-classification","display_name":"BCS classification","score":0.8199999928474426},{"id":"https://openalex.org/keywords/sotalol","display_name":"sotalol","score":0.6690000295639038},{"id":"https://openalex.org/keywords/metoprolol","display_name":"metoprolol","score":1.0},{"id":"https://openalex.org/keywords/intestinal-permeability","display_name":"intestinal permeability","score":0.7639999985694885},{"id":"https://openalex.org/keywords/ph-dependent-permeability","display_name":"pH-dependent permeability","score":0.9620000123977661},{"id":"https://openalex.org/keywords/caco-2-permeability","display_name":"Caco-2 permeability","score":0.8180000185966492},{"id":"https://openalex.org/keywords/intestinal-segments","display_name":"intestinal segments","score":0.6940000057220459},{"id":"https://openalex.org/keywords/ionization","display_name":"ionization","score":0.621999979019165},{"id":"https://openalex.org/keywords/pka","display_name":"pKa","score":0.7210000157356262},{"id":"https://openalex.org/keywords/drug-absorption","display_name":"drug absorption","score":0.6119999885559082},{"id":"https://openalex.org/keywords/beta-blockers","display_name":"beta-blockers","score":0.6389999985694885},{"id":"https://openalex.org/keywords/immediate-release-formulation","display_name":"immediate-release formulation","score":0.6000000238418579},{"id":"https://openalex.org/keywords/physicochemical-properties","display_name":"physicochemical properties","score":0.5720000267028809}],"concepts":[{"id":"https://openalex.org/C2776639339","wikidata":"https://www.wikidata.org/wiki/Q413591","display_name":"Sotalol","level":3,"score":0.814612865447998},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7379043698310852},{"id":"https://openalex.org/C2781280847","wikidata":"https://www.wikidata.org/wiki/Q409468","display_name":"Metoprolol","level":2,"score":0.7322578430175781},{"id":"https://openalex.org/C2781071285","wikidata":"https://www.wikidata.org/wiki/Q17141320","display_name":"Intestinal permeability","level":2,"score":0.7079780101776123},{"id":"https://openalex.org/C120882062","wikidata":"https://www.wikidata.org/wiki/Q28352","display_name":"Permeability (electromagnetism)","level":3,"score":0.6285603642463684},{"id":"https://openalex.org/C2777226302","wikidata":"https://www.wikidata.org/wiki/Q233345","display_name":"Ileum","level":2,"score":0.5233874917030334},{"id":"https://openalex.org/C2776366702","wikidata":"https://www.wikidata.org/wiki/Q185765","display_name":"Jejunum","level":2,"score":0.5218997597694397},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4805796146392822},{"id":"https://openalex.org/C2778131192","wikidata":"https://www.wikidata.org/wiki/Q241549","display_name":"Antiarrhythmic agent","level":3,"score":0.4401891231536865},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.4026990234851837},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.2201451063156128},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20403972268104553},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1938856542110443},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.1613609790802002},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.0},{"id":"https://openalex.org/C2780074459","wikidata":"https://www.wikidata.org/wiki/Q389735","display_name":"Heart disease","level":2,"score":0.0},{"id":"https://openalex.org/C41625074","wikidata":"https://www.wikidata.org/wiki/Q176088","display_name":"Membrane","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002626","descriptor_name":"Chemistry, Pharmaceutical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006863","descriptor_name":"Hydrogen-Ion Concentration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007408","descriptor_name":"Intestinal Absorption","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008790","descriptor_name":"Metoprolol","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008790","descriptor_name":"Metoprolol","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D010539","descriptor_name":"Permeability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010599","descriptor_name":"Pharmacokinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D013015","descriptor_name":"Sotalol","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013015","descriptor_name":"Sotalol","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D013810","descriptor_name":"Therapeutic Equivalency","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014486","descriptor_name":"United States Food and Drug Administration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018938","descriptor_name":"Caco-2 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/mp100175a","doi":"https://doi.org/10.1021/mp100175a","is_oa":false,"landing_page_url":"https://doi.org/10.1021/mp100175a","pdf_url":null,"source":{"id":"https://openalex.org/S204562082","display_name":"Molecular Pharmaceutics","issn_l":"1543-8384","issn":["1543-8384","1543-8392"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmaceutics","raw_type":"journal-article"},{"id":"pmid:20701326","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20701326","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular pharmaceutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":44,"referenced_works":["https://openalex.org/W15770653","https://openalex.org/W1498305210","https://openalex.org/W1499935265","https://openalex.org/W1570500347","https://openalex.org/W1581200378","https://openalex.org/W1971748087","https://openalex.org/W1971897937","https://openalex.org/W1974574813","https://openalex.org/W1976943394","https://openalex.org/W1985785813","https://openalex.org/W1994426638","https://openalex.org/W1997523656","https://openalex.org/W2006467011","https://openalex.org/W2007586400","https://openalex.org/W2020148093","https://openalex.org/W2020853269","https://openalex.org/W2023347369","https://openalex.org/W2024545614","https://openalex.org/W2028133542","https://openalex.org/W2038299379","https://openalex.org/W2054666684","https://openalex.org/W2060992818","https://openalex.org/W2070482283","https://openalex.org/W2072922667","https://openalex.org/W2078565354","https://openalex.org/W2086026747","https://openalex.org/W2088961994","https://openalex.org/W2091015790","https://openalex.org/W2092304430","https://openalex.org/W2094422849","https://openalex.org/W2097275187","https://openalex.org/W2101171473","https://openalex.org/W2102182534","https://openalex.org/W2110278176","https://openalex.org/W2112722416","https://openalex.org/W2129827408","https://openalex.org/W2130247507","https://openalex.org/W2140661985","https://openalex.org/W2142400726","https://openalex.org/W2154889565","https://openalex.org/W2155451228","https://openalex.org/W2156321359","https://openalex.org/W2159938476","https://openalex.org/W2171654601"],"related_works":["https://openalex.org/W2092538548","https://openalex.org/W1966640934","https://openalex.org/W1976943394","https://openalex.org/W1968266097","https://openalex.org/W3110633568","https://openalex.org/W2047575785","https://openalex.org/W2325373291","https://openalex.org/W2055791131","https://openalex.org/W1993973743","https://openalex.org/W2409194750"],"abstract_inverted_index":{"The":[0,45,63],"FDA":[1,72],"classifies":[2],"a":[3,71,300],"drug":[4],"substance":[5],"as":[6],"high-permeability":[7],"when":[8],"the":[9,34,53,75,83,96,143,171,176,187,203,229,235,240,260,295,315,322],"fraction":[10,304],"of":[11,47,67,145,167,193,262,305],"dose":[12,192,306],"absorbed":[13,201],"(F(abs))":[14],"in":[15,82,87,99,202,282,292,314],"humans":[16],"is":[17,217,248,285],"90%":[18],"or":[19],"higher.":[20],"This":[21],"direct":[22],"correlation":[23],"between":[24,59,288],"human":[25],"permeability":[26,60,139,144,230,242,247],"and":[27,41,61,69,113,121,156,165,174,228,253,267,290],"F(abs)":[28,39,291],"has":[29,195,302],"been":[30,196],"recently":[31],"controversial,":[32],"since":[33],"\u03b2-blocker":[35],"sotalol":[36,68,122,136,146],"showed":[37,123,137],"high":[38,274,303],"(90%)":[40],"low":[42,249],"Caco-2":[43],"permeability.":[44],"purpose":[46],"this":[48,57],"study":[49],"was":[50],"to":[51,95,198],"investigate":[52],"scientific":[54],"basis":[55],"for":[56,74,222,239,272],"disparity":[58],"F(abs).":[62,275],"effective":[64],"permeabilities":[65],"(P(eff))":[66],"metoprolol,":[70],"standard":[73],"low/high":[76,241],"P(eff)":[77,128,212,289],"class":[78,243],"boundary,":[79],"were":[80],"investigated":[81],"rat":[84],"perfusion":[85],"model,":[86],"three":[88],"different":[89],"intestinal":[90,324],"segments":[91],"with":[92,126],"pHs":[93],"corresponding":[94],"physiological":[97],"pH":[98,105,111,117,149,154,215,232,251,256,265],"each":[100],"region:":[101],"(1)":[102],"proximal":[103],"jejunum,":[104,316],"6.5;":[106],"(2)":[107],"mid":[108],"small":[109,205],"intestine,":[110],"7.0;":[112],"(3)":[114],"distal":[115],"ileum,":[116],"7.5.":[118],"Both":[119],"metoprolol":[120,194,263],"pH-dependent":[124],"permeability,":[125],"higher":[127,130],"at":[129,148,153,214,231,250,255,264,318],"pH.":[131],"At":[132],"any":[133],"given":[134],"pH,":[135],"lower":[138],"than":[140],"metoprolol;":[141],"however,":[142],"determined":[147],"7.5":[150,216,257],"exceeded/matched":[151],"metoprolol's":[152,211],"6.5":[155,233,252,266],"7.0,":[157,254,268],"respectively.":[158],"Physicochemical":[159],"analysis":[160],"based":[161],"on":[162],"ionization,":[163],"pK(a)":[164],"partitioning":[166,184],"these":[168,179],"drugs":[169],"predicted":[170],"same":[172],"trend":[173],"clarified":[175],"mechanism":[177],"behind":[178],"observed":[180],"results.":[181],"Experimental":[182],"octanol-buffer":[183],"experiments":[185],"confirmed":[186],"theoretical":[188],"curves.":[189],"An":[190],"oral":[191],"reported":[197],"be":[199],"completely":[200],"upper":[204],"intestine;":[206],"it":[207,258,308],"follows,":[208],"hence,":[209],"that":[210],"value":[213,238],"not":[218,312],"likely":[219,270],"physiologically":[220],"relevant":[221,237,323],"an":[223],"immediate":[224],"release":[225],"dosage":[226],"form,":[227],"represents":[234],"actual":[236],"boundary.":[244],"Although":[245],"sotalol's":[246,293],"exceeds/matches":[259],"threshold":[261],"most":[269],"responsible":[271],"its":[273],"In":[276],"conclusion,":[277],"we":[278],"have":[279,310],"shown":[280],"that,":[281,298],"fact,":[283],"there":[284],"no":[286],"discrepancy":[287],"absorption;":[294],"data":[296],"emphasize":[297],"if":[299],"compound":[301],"absorbed,":[307],"will":[309],"high-permeability,":[311],"necessarily":[313],"but":[317],"some":[319],"point":[320],"along":[321],"regions.":[325]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2124278256","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":10},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":17},{"year":2013,"cited_by_count":15},{"year":2012,"cited_by_count":15}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
